CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Prognostic value of F-18-FDG PET/CT in a large cohort of 495 patients with advanced neuroendocrine neoplasms (NEN) treated with peptide receptor radionuclide therapy (PRRT)
DOI 10.1055/s-0039-1683742
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Zhang, HR Kulkarni, A Singh, K Niepsch, RP Baum
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe02/2019
Jahrgang / SeitenJg. 58
Kernaussage aus der Literatur
Abstract-Vorschau
Prognostic value of F-18-FDG PET/CT in a large cohort of 495 patients with advanced neuroendocrine neoplasms (NEN) treated with peptide receptor radionuclide therapy (PRRT)
Zitieren
Zitierempfehlung
J Zhang, HR Kulkarni, A Singh, K Niepsch, RP Baum (2019) Prognostic value of F-18-FDG PET/CT in a large cohort of 495 patients with advanced neuroendocrine neoplasms (NEN) treated with peptide receptor radionuclide therapy (PRRT). Nuklearmedizin - NuclearMedicine, 58 (02). https://doi.org/10.1055/s-0039-1683742
Mit CareLit weiterarbeiten